Hematology and Oncology- Physiology Flashcards
Hematopoiesis- organs
“Young Liver Synthesizes Blood”
Yolk Sac
Liver
Spleen
Bone Marrow
Hemoglobin development
“Always Alpha, Gamma Goes, Becomes Beta”
gamma-epsilon (Embryonic- yolk sac)
alpha2-gamma2 (HbF- fetus)
alpha2-beta2 (HbA1- adult)
alpha2-delta2 (HbA2- adult)
Characteristics of HbF
Less 2,3- BPG affinity (makes sense because it is shifting the curve left, to increase O2 affinity/ O2 binding- to extract from mom’s HbA1 and HbA2)
ABO classification
A- Has A surface antigens, make IgM Abs to B
B- Has B surface antigens, makes IgM Abs to A
AB- has both A and B surface antigens; makes no Abs
O- has no surface antigens; makes IgM Abs to both A and B
Rh classification
Rh+ –> has D surface antigens; does not make antibodies
Rh- –> has no D surface antigens; makes IgG Abs to D
Clinically important when mom is Rh- and kid is Rh+ (mom makes Abs to kids blood, that can potentially kill kid)
Therefore, give mom RhoGam (Anti-D IgG; to clear fetuses RBCs and prevent her from making her own anti-D IgG)
Gets worse during subsequent pregnancies, if not treated during the first one (because pre-formed Anti-D IgG are in mom’s circulation)
Erythroblastosis fetalis- S&S
Hemolytic disease of the newborn
Neonates present with purpura, HSM, anemia, edema, ascites (placenta is pale, thick and enlarged)
ABO hemolytic disease of the newborn
Most common
Don’t hear about as often, because antibodies to A or B antigens that are not present on the cell is generally IgM (which does not cross the placenta)
Occasionally (most common in a Type O mom) with a A or B fetus, IgG is produced that then reacts with kids RBCs
This generally does not worsen with subsequent pregnancies, and kid presents with mild jaundice that is corrected with phototherapy/ exchange transfusion when baby is delivered
Hemoglobin electrophoresis
“A Fat Santa Claus”
Anode (+)
HbA
HbF
HbS (glutamic acid (-) is replaced with valine (neutral))
HbC (glutamic acid (-) is replaced with lysine (+))
Cathode (-)
Intrinsic pathway
12, 11, 9, 8
Extrinsic pathway
7
Combined pathway
10, 5, 2, 1, 13 (stabilizes 1)
Procoagulation
Oxidized Vitamin K (enzyme: epoxide reductase- inhibited by Warfarin) –> Reduced Vitamin K –> activates 2, 7, 9, 10, C, S (via gamma glutamyl transferase)
Anticoagulation- Protein C
Protein C (via thrombin-thrombomodulin complex) –> activated Protein C (via protein S) –> cleaves and inactivates Va and VIIIa
Therefore Protein C plays a role in anticoagulation
Anticoagulation- Plasminogen
Plasminogen (via tPA) –> Plasmin –> Fibrinolysis (1. cleaves fibrin mesh, 2. destruction of coagulation factors)
Anticoagulation- Antithrombin
Main targets of antithrombin: thrombin and Xa
Inhibits activated form of factors II, VII, IX, X, XI, XII
Heparin enhances the activity of antithrombin
Factor V Leiden mutation
Produces a factor V that is resistant to being inactivated by Protein C –> thereby makes individual in a hypercoagulable state
tPA
Activates Plasminogen to Plasmin
Used clinically as a thrombolytic
Platelet pathway (primary hemostasis)
Injury –> Exposure –> Adhesion –> Activation –> Aggregation
Injury
Endothelial damage
Exposure
vWF binds to exposed collagen
vWF is in endothelial cells and platelet granules
Adhesion
Platelets bind vWF via GpIb receptors –> Platelets undergo a conformational change –> Platelets release ADP and Ca2+ –> ADP helps platelet adheres to endothelium
Activation
ADP binding to receptor induces GpIIb/IIIa expression at platelet surface
Aggregation
Fibrinogen binds GpIIb/IIIa receptors and links platelets
Pro-aggregation factors
TXA2 (released by platelets)
Decrease blood flow
Increase platelet aggregation
Anti-aggregation factors
PGI2 and NO (released by endothelial cells)
Increase blood flow
Decrease platelet aggregation
Aspirin
Irreversibly inhibits COX (TXA2 synthesis)
Clopidogrel
Inhibits ADP-induced expression of GpIIb/IIIa
Abciximab
Inhibit GpIIb/IIIa directly
Ristocetin
Activates vWF to bind to GpIb
Failure of agglutination indicates von Willibrand disease and Bernard Soulier syndrome (GpIb deficiency)
Glanzmann throbastehenia
Deficiency of GpIIb/IIIa